RESUMO
In the United States, diabetes is the seventh leading cause of death and continues to rise in prevalence, with type 2 diabetes accounting for 90-95% of all cases. Rates of diabetes in Kentucky, and, in particular, the Appalachian region, are among the highest in the nation and are increasing faster than the national average. Despite this disproportionate burden, barriers to clinical appointment attendance have not been fully explored in this population. This article examines the association among perceived barriers to clinical attendance, glycemic control, and diabetes self-care as part of an ongoing study. We used a 25-item checklist developed using the Chronic Care Model to assess participants' barriers to clinic attendance. Glycemic control was assessed via A1C measurement. Diabetes self-care was assessed using the Summary of Diabetes Self-Care Activities measure. At the time of analysis, 123 of the 356 participants (34.6%) did not report any barriers to clinic attendance. For the remainder, the major reported barriers included forgetting appointments, inability to afford medicines or other treatment, and placing faith above medical care. The average A1C was 7.7%, and the average diabetes self-care summary score was 17.1 out of 35 points (with higher values indicating better self-care). Missing clinic appointments is associated with lower health outcomes, especially in vulnerable populations. This study can help educate clinic staff on perceived barriers to type 2 diabetes management among people with diabetes in Appalachia.
RESUMO
IN BRIEF Women with a history of gestational diabetes mellitus (GDM) are at higher risk for type 2 diabetes. This project piloted the National Diabetes Prevention Program lifestyle change program in cohorts of women with a history of GDM. The article describes recruitment efforts, challenges, and study participation and provides recommendations for future program implementation.
RESUMO
When you have diabetes, monitoring your blood glucose is a crucial part of your treatment plan. Knowing your blood glucose values can help you avoid short-term problems such as hyperglycemia (high blood glucose) and hypoglycemia (low blood glucose). Ongoing optimal blood glucose control can help you prevent or delay long-term diabetes complications such as diabetes-related eye disease, kidney disease and nerve damage.
Assuntos
Automonitorização da Glicemia , Glicemia/metabolismo , Diabetes Mellitus/metabolismo , Hiperglicemia/diagnóstico , Hipoglicemia/diagnóstico , Monitorização Fisiológica , Humanos , Hiperglicemia/metabolismo , Hipoglicemia/metabolismoRESUMO
PURPOSE: The purpose of this study was to determine whether COVID-19 impact and Diabetes Self-Management Education and Support (DSMES) service attendance predicted diabetes distress among individuals with type 2 diabetes during the pandemic. METHODS: Eighty-six adults with type 2 diabetes who either attended (n = 29) or did not previously attend (n = 57) DSMES services completed a cross-sectional survey. Participants' mean age was 57 ± 12.3 years, 50% were female, and 71.3% were diagnosed with diabetes >5 years. The Coronavirus Impact Scale was used to measure impact of the pandemic on daily life. The Diabetes Distress Scale was used to measure distress overall and within 4 subscales (emotional burden, interpersonal distress, physician-related distress, regimen distress). Separate multiple linear regressions were conducted for each outcome, controlling for age, sex, marital status, financial status, and time since diabetes diagnosis. RESULTS: Higher COVID-19 impact predicted higher diabetes-related distress for all subscales and overall. Only the subscale for interpersonal distress was predicted by DSMES attendance, which decreased with DSMES attendance. CONCLUSION: This study identifies a link between the effects of the COVID-19 pandemic and diabetes distress. The findings highlight the negative impact of the pandemic on diabetes distress and the importance of DSMES services for diabetes-related distress. Interventions are needed to reduce psychological distress among this population during public health crises.
Assuntos
COVID-19 , Diabetes Mellitus Tipo 2 , Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Idoso , Masculino , Diabetes Mellitus Tipo 2/complicações , Estudos Transversais , Pandemias , COVID-19/epidemiologia , EscolaridadeAssuntos
Diabetes Mellitus/terapia , Exercício Físico/psicologia , Comportamentos Relacionados com a Saúde , Motivação , Biomarcadores/sangue , Glicemia/metabolismo , Diabetes Mellitus/sangue , Diabetes Mellitus/fisiopatologia , Diabetes Mellitus/psicologia , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Aptidão Física , Fatores de TempoAssuntos
Atletas , Diabetes Mellitus Tipo 1/tratamento farmacológico , Exercício Físico , Temperatura Alta , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Estudantes , Automonitorização da Glicemia , Dieta , Gerenciamento Clínico , Humanos , Hiperglicemia/prevenção & controle , Hipoglicemia/prevenção & controle , Sistemas de Infusão de InsulinaAssuntos
Direitos Civis , Diabetes Mellitus Tipo 1/terapia , Crianças com Deficiência , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Pais , Instituições Acadêmicas , Adolescente , Automonitorização da Glicemia , Criança , Gerenciamento Clínico , Fármacos Gastrointestinais/uso terapêutico , Glucagon/uso terapêutico , Glucose/uso terapêutico , Humanos , Hipoglicemia/induzido quimicamente , Hipoglicemia/diagnóstico , Hipoglicemia/tratamento farmacológico , Técnicas de Planejamento , Edulcorantes/uso terapêuticoAssuntos
Informação de Saúde ao Consumidor , Atenção à Saúde , Diabetes Mellitus/terapia , Registros Eletrônicos de Saúde , Acesso dos Pacientes aos Registros , Atitude Frente aos Computadores , Diabetes Mellitus/diagnóstico , Diabetes Mellitus/psicologia , Health Insurance Portability and Accountability Act , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Internet , Autocuidado , Estados UnidosAssuntos
Diabetes Mellitus Tipo 2/terapia , Saúde da Família , Nível de Saúde , Estilo de Vida , Comportamento de Redução do Risco , Biomarcadores/sangue , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/epidemiologia , Dieta para Diabéticos , Exercício Físico , Humanos , Fatores de RiscoAssuntos
Diabetes Mellitus Tipo 1/tratamento farmacológico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Sistemas de Liberação de Medicamentos/instrumentação , Hipoglicemiantes/administração & dosagem , Sistemas de Infusão de Insulina , Insulina/administração & dosagem , Adolescente , Comportamento do Adolescente , Biomarcadores/sangue , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Criança , Comportamento Infantil , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/diagnóstico , Desenho de Equipamento , Humanos , Injeções Subcutâneas , Adesão à Medicação , Resultado do TratamentoRESUMO
INTRODUCTION: The Diabetes Prevention Program, an intensive lifestyle change program, effectively reduces the risk of progression from prediabetes to type 2 diabetes but is underutilized. An implementation study using formative research was undertaken to increase Diabetes Prevention Program referrals at a primary care clinic. STUDY DESIGN: A pragmatic, cluster randomized, mixed-methods study. SETTING/PARTICPANTS: Clusters were teams of primary care clinicians from 2 primary care clinics. The 3 intervention clusters had 8-11 clinicians, and the 3 control clusters had 7-20 clinicians. INTERVENTION: Implementation activities occurred from December 2017 to February 2019. The activities included targeted clinician education, a prediabetes clinician champion, and a custom electronic health record report identifying patients with prediabetes. MAIN OUTCOME MEASURES: The primary outcome was referral of patients with prediabetes to the institutional Diabetes Prevention Program. Study data, including patient demographic and clinical variables, came from electronic health record. Interviews with clinicians evaluated the implementation strategies. Generalized estimating equation analyses that accounted for multiple levels of correlation and interview content analysis occurred in 2019. RESULTS: Study clinicians cared for 2,992 patients with a prediabetes diagnosis or HbA1c indicative of prediabetes (5.7%-6.4%). Clinicians in the intervention clusters referred 6.9% (87 of 1,262) of patients with prediabetes to the Diabetes Prevention Program and those in the control clusters referred 1.5% (26 of 1,730). When adjusted for patient age, sex, race, HbA1c value, HbA1c test location, and insurance type, intervention clinicians had 3.85 (95% CI=0.40, 36.78) greater odds of referring a patient with prediabetes to the Diabetes Prevention Program. The 11 interviewed intervention clinicians had mixed opinions about the utility of the interventions, reporting the prediabetes clinic champion (n=7, 64%) and educational presentations (n=6, 55%) as most helpful. CONCLUSIONS: Intervention clinicians were more likely to make Diabetes Prevention Program referrals; however, the study lacked power to achieve statistical significance. Clinician interviews suggested that intervention components that triggered Diabetes Prevention Program referrals varied among clinicians.